Journal of Medicinal Chemistry (4) Guse, A. H. Second messenger function and the structure− activity relationship of cyclic adenosine diphosphoribose (cADPR). FEBS J. 2005, 272, 4590−4597. (5) Guse, A. H. Regulation of calcium signaling by the second messenger cyclic adenosine diphosphoribose (cADPR). Curr. Mol. Med. 2004, 4, 239−248. (6) Lee, H. C.; Aarhus, R.; Levitt, D. The crystal structure of cyclic ADP-ribose. Nat. Struct. Biol. 1994, 1, 143−144. (7) Zhang, F. J.; Gu, Q. M.; Sih, C. J. Bioorganic chemistry of cyclic ADP-ribose (cADPR). Bioorg. Med. Chem. 1999, 7, 653−664. (8) Lee, H. C. Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective from cyclic ADP-ribose and NAADP. Curr. Mol. Med. 2004, 4, 227−237. (9) Bai, N.; Lee, H. C.; Laher, I. Emerging role of cyclic ADP-ribose (cADPR) in smooth muscle. Pharmacol. Ther. 2005, 105, 189−207. (10) Galione, A.; Churchill, G. C. Interactions between calcium release pathways: multiple messengers and multiple stores. Cell Calcium 2002, 32, 343−354. (11) Potter, B. V. L; Walseth, T. F. Medicinal chemistry and pharmacology of cyclic ADP-ribose. Curr. Mol. Med. 2004, 4, 303−311. (12) Guse, A. H.; Cakir-Kiefer, C.; Fukuoka, M.; Shuto, S.; Weber, K.; Bailey, V. C.; Matsuda, A.; Mayr, G. W.; Oppenheimer, N.; Schuber, F.; Potter, B. V. L Novel hydrolysis-resistant analogues of cyclic ADP-ribose: modification of the “northern” ribose and calcium release activity. Biochemistry 2002, 41, 6744−6751. (13) Ashamu, G. A.; Sethi, J. K.; Galione, A.; Potter, B. V. L Roles for adenosine ribose hydroxyl groups in cyclic adenosine 5′-diphosphate ribose-mediated Ca2+-release. Biochemistry 1997, 36, 9509−9517. (14) Shuto, S.; Fukuoka, M.; Manikowsky, A.; Ueno, Y.; Nakano, T.; Kuroda, R.; Kuroda, H.; Matsuda, A. Total synthesis of cyclic ADP- carbocyclic ribose, a stable mimic of Ca2+-mobilizing second messenger cyclic ADP-ribose. J. Am. Chem. Soc. 2001, 123, 8750− 8759. (15) Ashamu, G. A.; Galione, A.; Potter, B. V. L Chemoenzymatic synthesis of analogs of the 2nd messenger candidate cyclic adenosine 5′-diphosphate ribose. Chem. Commun. 1995, 1359−1360. (16) Walseth, T. F.; Lee, H. C. Synthesis and characterization of antagonists of cyclic ADP-ribose-induced Ca2+-release. Biochim. Biophys. Acta 1993, 1178, 235−242. (17) Sethi, J. K.; Empson, R. M.; Bailey, V. C.; Potter, B. V. L; Galione, A. 7-Deaza-8-bromo-cyclic ADP-ribose, the first membrane- permeant, hydrolysis-resistant cyclic ADP-ribose antagonist. J. Biol. Chem. 1997, 272, 16358−16363. (18) Guse, A. H.; da Silva, C. P.; Berg, I.; Skapenko, A. L.; Weber, K.; Heyer, P.; Hohenegger, M.; Ashamu, G. A.; Schulze-Koops, H.; Potter, B. V. L; Mayr, G. W. Regulation of calcium signalling in T-lymphocytes by the second messenger cyclic ADP-ribose. Nature 1999, 398, 70−73. (19) Rakovic, S.; Galione, A.; Ashamu, G. A.; Potter, B. V. L; Terrar, D. A. A specific cyclic ADP-ribose antagonist inhibits cardiac excitation−contraction coupling. Curr. Biol. 1996, 6, 989−996. (20) Zhang, B.; Wagner, G. K.; Weber, K.; Garnham, C.; Morgan, A. J.; Galione, A.; Guse, A. H.; Potter, B. V. L. 2′-Deoxy cyclic adenosine 5′-diphosphate ribose derivatives:importance of the 2′-hydroxyl motif for the antagonistic activity of 8-substituted cADPR derivatives. J. Med. Chem. 2008, 51, 1623−1636. (21) Shuto, S.; Fukuoka, M.; Kudoh, T.; Garnham, C.; Galione, A.; Potter, B. V. L; Matsuda, A. Convergent synthesis and unexpected Ca2+-mobilizing activity of 8-substituted analogues of cyclic ADP- carbocyclic-ribose, a stable mimic of the Ca2+-mobilizing second messenger cyclic ADP-ribose. J. Med. Chem. 2003, 46, 4741−4749. (22) Reyes-Harde, M.; Potter, B. V. L; Galione, A.; Stanton, P. K. Induction of hippocampal LTD requires nitric-oxide-stimulated PKG activity and Ca2+ release from cyclic ADP-ribose-sensitive stores. J. Neurophysiol. 1999, 82, 1569−1576. (23) Reyes-Harde, M.; Empson, R.; Potter, B. V. L; Galione, A.; Stanton, P. K. Evidence of a role for cyclic ADP-ribose in long-term synaptic depression in hippocampus. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4061−4066. Article (24) Bailey, V. C.; Sethi, J. K.; Galione, A.; Potter, B. V. L Synthesis of 7-deaza-8-bromo cyclic adenosine 5′-diphosphate ribose: the first hydrolysis resistant antagonist at the cADPR receptor. Chem. Commun. 1997, 695−696. (25) Zhang, B.; Bailey, V. C.; Potter, B. V. L. Chemoenzymatic synthesis of 7-deaza cyclic adenosine 5′-diphosphate ribose analogues, membrane permeant modulators of intracellular calcium release. J. Org. Chem. 2007, 73, 1693−1703. (26) Guse, A. H.; Gu, X. F.; Zhang, L. R.; Weber, K.; Kramer, E.; Yang, Z. J.; Jin, H. W.; Li, Q.; Carrier, L.; Zhang, L. H. A minimal structural analogue of cyclic ADP-ribose. Synthesis and calcium release activity in mammalian cells. J. Biol. Chem. 2005, 280, 15952−15959. (27) Xu, J.; Yang, Z.; Dammermann, W.; Zhang, L.; Guse, A. H.; Zhang, L. H. Synthesis and agonist activity of cyclic ADP-ribose analogues with substitution of the nothern ribose by ether or alkane chains. J. Med. Chem. 2006, 49, 5501−5512. (28) Wagner, G. K.; Black, S.; Guse, A. H.; Potter, B. V. L First enzymatic synthesis of an N1-cyclised cADPR (cyclic ADP-ribose) analogue with a hypoxanthine partial structure: discovery of a mem- brane permeant cADPR agonist. Chem. Commun. 2003, 1944−1945. (29) Kirchberger, T.; Moreau, C.; Wagner, G. K.; Fliegert, R.; Siebrands, C. C.; Nebel, M.; Schmid, F.; Harneit, A.; Odoardi, F.; Flugel, A.; Potter, B. V. L.; Guse, A. H. 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist. Biochem. J. 2009, 422, 139−149. (30) Wagner, G. K.; Guse, A. H.; Potter, B. V. L. Rapid synthetic route toward structurally modified derivatives of cyclic adenosine 5′- diphosphate ribose. J. Org. Chem. 2005, 70, 4810−4819. (31) Liu, Q.; Kriksunov, I. A.; Moreau, C.; Graeff, R.; Potter, B. V. L.; Lee, H. C.; Hao, Q. Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolysable sub- strate analog. J. Biol. Chem. 2007, 282, 24825−24832. (32) Zhang, F. J.; Sih, C. J. Enzymatic cyclization of 1,N-6-etheno- nicotinamide adenine-dinucleotide. Bioorg. Med. Chem. Lett. 1995, 5, 1701−1706. (33) Graeff, R. M.; Walseth, T. F.; Hill, H. K.; Lee, H. C. Fluorescent analogs of cyclic ADP-ribose: synthesis, spectral characterization, and use. Biochemistry 1996, 35, 379−386. (34) Wilson, M. H.; McCloskey, J. A. Isotopic labeling studies of the base-catalyzed conversion of 1-methyladenosine to N6-methyladeno- sine. J. Org. Chem. 1973, 38, 2247−2248. (35) Love, M. L.; Szebenyi, D. M. E.; Kriksunov, I. A.; Thiel, D. J.; Munshi, C.; Graeff, R.; Lee, H. C.; Hao, Q. ADP-ribosyl cyclase: crystal structures reveal a covalent intermediate. Structure 2004, 12, 477−486. (36) Atkinson, M. R.; Morton, R. K.; Jackson, J. F.; Murray, A. W. Nicotinamide of 6-mercaptopurine dinucleotide and related com- pounds: potential sources of 6-mercaptopurine nucleotide in chemo- therapy. Nature 1962, 196, 35−36. (37) Hughes, N. A.; Kenner, G. W.; Todd, A. Codehydrogenases. III. Synthesis of diphosphopyridine nucleotide (cozymase) and triphos- phopyridine nucleotide. J. Chem. Soc. 1957, 3733−3736. (38) Montgomery, J. A.; Thomas, H. J.; Schaeffer, H. J. Synthesis of potential anticancer agents. XXVIII. Simple esters of 6-mercaptopurine ribonucleotide. J. Org. Chem. 1961, 26, 1929−1933. (39) Imai, K.; Fujii, S.; Takanohashi, K.; Furukawa, Y.; Masuda, T.; Honjo, M. Phosphorylation. IV. Selective phosphorylation of the primary hydroxyl group in nucleosides. J. Org. Chem. 1969, 34, 1547−1550. (40) Ikemoto, T.; Haze, A.; Hatano, H.; Kitamoto, Y.; Ishida, M.; Nara, K. Phosphorylation of nucleosides with phosphorus oxychloride in trialkyl phosphate. Chem. Pharm. Bull. 1995, 43, 210−215. (41) Zderic, J. A.; Moffatt, J. G. Perchloric acid in the preparation of 2′,3′-isopropylidene 6-thioinosine. J. Med. Chem. 1965, 8, 275. (42) Wall, M.; Shim, J. H.; Benkovic, S. J. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis. Biochemistry 2000, 39, 11303−11311. (43) Coleman, R. S.; Siedlecki, J. M. Synthesis of a 4-thio-2′- deoxyuridine-containing oligonucleotide. Development of the thio- carbonyl group as a linker element. J. Am. Chem. Soc. 1992, 114, 9229−9230. 1488 dx.doi.org/10.1021/jm201127y | J. Med. Chem. 2012, 55, 1478−1489